Table 1 Cohort demographics.
| Â | Overall population sequenced N (%) | HIV-infected children N (%) | HIV non-infected children N (%) | P value |
|---|---|---|---|---|
# of participants | 169 | 87 (51.5) | 82 (48.5) | Â |
Sex | ||||
Female | 84 (50.6) | 44 (4.9) | 40 (48.8) | 0.878 |
Male | 85 (49.4) | 43 (52.1) | 42 (51.2) | Â |
Age | ||||
1–3 years | 15 (8.9) | 07 (8.1) | 08 (9.8) | 0.700 |
4–6 years | 24 (14.2) | 15 (17.2) | 09 (11) |  |
7–9 years | 42 (24.9) | 21 (24.1) | 21 (25.6) |  |
≥ 10 years | 88 (52.0) | 44 (50.6) | 44 (53.6) |  |
CD4+ cells/mm3 | ||||
< 200 | – | 5 (5.7) | NA |  |
200–499 | – | 18 (20.7) | NA |  |
≥ 500 | – | 64 (73.6) | NA |  |
Viral load copies/mL | ||||
Not detected | – | 40 (45.9) | NA |  |
< 150–1000 | – | 15 (17.2) | NA |  |
1001–10,000 | – | 13 (14.9) | NA |  |
> 10,000 | – | 19 (21.8) | NA |  |
ART regimens | ||||
Pis | – | 13 (14.9) | NA |  |
NNRTIs | – | 74 (85.1) | NA |  |
ART duration | ||||
< 1 year | – | 13 (14.9) | NA |  |
1–5 years | – | 37 (42.5) | NA |  |
6–10 years | – | 31 (35.6) | NA |  |
> 10 years | – | 6 (7.0) | NA |  |
